Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- Check4 days agoChange DetectedThe PATHFINDER record displays details of the completed avapritinib study, including its design, eligibility criteria, study locations, and measured outcomes. It also includes results-related publications, record dates, and study documents.SummaryDifference66%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the clinical study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH announcement banner about website changes and updated terminology appeared above the page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedA 403 Forbidden error page is displayed for the study page, replacing the usual study record content. The previously visible study documents and details appear removed or inaccessible due to the error.SummaryDifference19%

- Check60 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a new build of the page without changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.